At what point can the fda halt the development or use of gene therapy?
on submission of an ind application
during clinical trials
after manufacturing and marketing of the approved therapy
all of the answers are correct

the father in the first generation probably had the recessive colorblind trait in his x chromosome. if he and his wife both had the colorblind trait, even if she had 1 recessive and 1 dominant, then that trait would be passed on to their kids.

(since you didn't attach the family tree this is just an assumption)

i wish i could with all of them i can barley see the first one so here's the answer to the first one b

answer; endometriosis;